India’s Emerging Science, Technology and Innovation Conclave is scheduled for October 27–29 at Bharat Mandapam in New Delhi. The Prime Minister's Office set out the program in an October 26 announcement, placing links between research, industry and public policy at its center.
The office scheduled Prime Minister Narendra Modi to inaugurate the event on October 27. This article reports the published program and its policy stakes. It does not infer new funding, agreements or results from an opening ceremony.
At a glance
| Program item | Announced figure |
|---|---|
| Conclave dates | October 27–29 |
| Thematic areas | 12 |
| Startup stalls | About 150 |
| Global Connect invitees | More than 300 |
What the program includes
The PMO lists twelve thematic areas, including artificial intelligence, biotechnology, advanced materials, manufacturing, health, energy, climate and ocean science. Its announcement says discussions will address research priorities and ways to turn scientific work into practical applications.
The program includes a planned exhibition of about 150 deep-tech startup stalls. It also describes a Global Connect networking event for more than 300 invited participants from research, universities and industry in India and abroad.
Those numbers describe the announced program. They are not independently verified counts of attendance, completed partnerships or companies receiving public support. The distinction is important when assessing claims about an event's economic effect.
Analysis: what a research-to-industry policy must resolve
A forum can give researchers and businesses a place to identify shared problems. But moving a promising idea into use may also require testing, finance, skilled staff and a clear agreement about who can use the results. A meeting is one step in that process.
Public support can be justified when research has benefits that a single firm cannot capture. The countervailing concern is how support is allocated and who bears the risk of failure. A sound assessment would examine the rules for choosing projects, the evidence required and the way results are reported.
Access is another issue. A program aimed at linking science and industry should be judged partly on whether capable institutions and smaller firms can participate on fair terms. The number of stalls in an exhibition cannot answer that question on its own.
Commercial success is not the only possible measure. Research may be valuable for public health, resilience or knowledge even when it does not quickly produce a saleable product. The appropriate test should match the stated aim of the project, with costs and limits made visible.
These are analytical considerations, not claims that a particular participant has been favored or that a project will fail. No such allegation is supported by the program reviewed for this brief.
What to watch next
The useful follow-up is any published agreement, funding decision or implementation plan. Check whether an announcement describes an intention, a signed arrangement or work that has already begun. For a numerical claim, look for the period, denominator and source.
A later report on outcomes should also explain what changed because of the policy, rather than simply counting activity that would have occurred anyway. That comparison requires evidence collected over time.
Explore the India country guide and India policy watchlist for related context. This AI-assisted report was prepared on October 27, 2026, from the PMO's program announcement. It offers no investment advice, estimate of economic gains or claim that the event has already delivered its stated goals.
Photo and reporting note
File image for institutional context, not a photograph of the event reported here. Photo: DesiBoy101, original file, CC BY 4.0. Cropped for publication.
